CoreFirst Bank & Trust’s Novo Nordisk NVO Stock Holding History

CoreFirst Bank & Trust’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$226K	Hold	4,723	–	–	0.11%	110
2026 Q1	$174K	Hold	4,723	–	–	0.09%	124
2025 Q4	$240K	Hold	4,723	–	–	0.13%	109
2025 Q3	$262K	Sell	4,723 -62	-1%	-$3.63K	0.14%	104
2025 Q2	$330K	Hold	4,785	–	–	0.19%	94
2025 Q1	$332K	Hold	4,785	–	–	0.21%	90
2024 Q4	$412K	Sell	4,785 -41	-0.8%	-$4.43K	0.24%	79
2024 Q3	$575K	Hold	4,826	–	–	0.33%	66
2024 Q2	$689K	Hold	4,826	–	–	0.46%	56
2024 Q1	$620K	Sell	4,826 -530	-10%	-$63.1K	0.39%	63
2023 Q4	$554K	Hold	5,356	–	–	0.37%	66
2023 Q3	$487K	Buy	5,356 +62	+1%	+$5.46K	0.35%	71
2023 Q2	$428K	Hold	5,294	–	–	0.3%	80
2023 Q1	$421K	Hold	5,294	–	–	0.31%	78
2022 Q4	$358K	Hold	5,294	–	–	0.27%	90
2022 Q3	$264K	Sell	5,294 -98	-2%	-$5.25K	0.23%	97
2022 Q2	$300K	Sell	5,392 -660	-11%	-$36.6K	0.24%	95
2022 Q1	$336K	Sell	6,052 -168	-3%	-$8.62K	0.23%	96
2021 Q4	$348K	Sell	6,220 -20	-0.3%	-$1.08K	0.23%	98
2021 Q3	$300K	Sell	6,240 -124	-2%	-$6K	0.21%	107
2021 Q2	$266K	Hold	6,364	–	–	0.18%	116
2021 Q1	$215K	Sell	6,364 -160	-2%	-$5.7K	0.15%	129
2020 Q4	$228K	Buy	+6,524	New	+$225K	0.17%	113

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

CoreFirst Bank & Trust's NVO Position: Q2 2026 in Review

CoreFirst Bank & Trust held its Novo Nordisk (NVO) position steady in Q2 2026 at 4,723 shares worth $226K. The position accounts for 0.11% of the portfolio, ranked #110.

CoreFirst Bank & Trust first reported a position in NVO in Q4 2020 and has held it in 23 quarters since. The position peaked at $689K in Q2 2024. 1,354 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

CoreFirst Bank & Trust held 4,723 shares of Novo Nordisk worth $226K as of Q2 2026.
CoreFirst Bank & Trust left its Novo Nordisk share count unchanged in Q2 2026.
Novo Nordisk made up 0.11% of CoreFirst Bank & Trust's portfolio in Q2 2026, its #110 holding.
CoreFirst Bank & Trust first reported a position in Novo Nordisk in Q4 2020 and has held it in 23 quarters since.
CoreFirst Bank & Trust's Novo Nordisk position peaked at $689K in Q2 2024.
1,354 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on CoreFirst Bank & Trust's 13F filing for Q2 2026, filed 5 Aug 2026.